Sitala
Cambridge, GB · 1 known investors
Find your way into Sitala
Sign up to see every warm intro you have to Sitala
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sitala team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sitala Bio develops treatments targeting harmful inflammation for neurodegenerative and inflammatory diseases. It operates in the biotechnology and therapeutics sector.
Investors · 1
OrbiMedlisted by OrbiMedNew York · $1M – $75M
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Sitala do?
- Sitala Bio develops treatments targeting harmful inflammation for neurodegenerative and inflammatory diseases. It operates in the biotechnology and therapeutics sector.
- Who are Sitala's investors?
- Sitala's investors include OrbiMed.
- Where is Sitala headquartered?
- Sitala is headquartered in Cambridge, GB.
